Onco-Innovations Limited (NEO:ONCO)

Canada flag Canada · Delayed Price · Currency is CAD
2.070
+0.020 (0.98%)
Jul 23, 2025, 4:00 PM EDT
0.98%
Market Cap98.68M
Revenue (ttm)65.29K
Net Income (ttm)-8.49M
Shares Out54.22M
EPS (ttm)-0.24
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume5,905
Average Volume158,929
Open2.050
Previous Close2.050
Day's Range2.050 - 2.070
52-Week Range0.560 - 2.800
Betan/a
RSI56.92
Earnings DateAug 1, 2025

About Onco-Innovations

Onco-Innovations Limited, a pre-clinical stage biotechnology company, develops drug candidates for cancer treatments. The company’s lead product candidate is ONC010, a novel inhibitor of the DNA repair enzyme a Polynucleotide Kinase 3′-Phosphatase (PNKP) in a nanoparticle formulation based on the drug delivery technology. Onco-Innovations Limited is headquartered in Calgary, Canada. [Read more]

Industry Biological Products, Except Diagnostic Substances
CEO Thomas O’Shaughnessy
Employees 1
Stock Exchange Cboe Canada
Ticker Symbol ONCO
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.